The Antidote: Takeover Targets Are Choosing To Swallow Poison Pills

With hostile takeovers back in the spotlight once again, we are seeing the return of the classic takeover defence: the poison pill. Indeed, in a market where valuations remain relatively cheap, a number of companies have become attractive takeover targets - especially those run by boards with only a small shareholding in the firm. But this is not to say that corporates are defenceless in the face of unfriendly bids.

To read the full article, please choose one of the following options: